We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
(+18%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
12.74%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$363M |
| 2 |
Tencent Music
TME
|
+$184M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$182M |
| 4 |
Baidu
BIDU
|
+$146M |
| 5 |
Gaotu Techedu
GOTU
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$204M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$189M |
| 3 |
Zoetis
ZTS
|
+$182M |
| 4 |
Guardant Health
GH
|
+$136M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 13.15% |
| 3 | Technology | 10.68% |
| 4 | Financials | 9.81% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
BARK
BARK
$78.4M
| $366K | ﹤0.01% |
+1,648
| New | +$435K |
|
2052
Genuine Parts
GPC
$17.9B
| $366K | ﹤0.01% |
+3,165
| New | +$337K |
|
2053
Transmedics
TMDX
$2.64B
| $365K | ﹤0.01% |
+8,805
| New | +$271K |
|
2054
Victory Capital Holdings
VCTR
$6.28B
| $363K | ﹤0.01% |
14,198
-9,439
| -40% | -$231K |
|
2055
Keros Therapeutics
KROS
$199M
| $362K | ﹤0.01% |
5,877
-11,615
| -66% | -$736K |
|
2056
Pan American Silver
PAAS
$18.2B
| $362K | ﹤0.01% |
+12,047
| New | +$391K |
|
2057
Silicon Laboratories
SLAB
$7.17B
| $362K | ﹤0.01% |
+2,569
| New | +$368K |
|
2058
Grupo Aval
AVAL
$5.79B
| $361K | ﹤0.01% |
+58,054
| New | +$379K |
|
2059
CALL
Berkshire Hathaway Class B
BRK.B
$1.11T
| $358K | ﹤0.01% |
+1,400
| New | +$340K |
|
2060
Nexa Resources
NEXA
$1.64B
| $358K | ﹤0.01% |
+34,951
| New | +$343K |
|
|
NLSN
2061
DELISTED
Nielsen Holdings plc
NLSN
| $358K | ﹤0.01% |
14,253
-99,184
| -87% | -$2.34M |
|
|
QNGY
2062
DELISTED
Quanergy Systems, Inc.
QNGY
| $357K | ﹤0.01% |
1,787
-21,493
| -92% | -$4.6M |
|
|
ARCH
2063
DELISTED
Arch Resources, Inc.
ARCH
| $357K | ﹤0.01% |
8,574
-18,310
| -68% | -$882K |
|
2064
The Mosaic Company
MOS
$7.34B
| $356K | ﹤0.01% |
11,254
-5,711
| -34% | -$168K |
|
2065
MMTec
MTC
$328M
| $355K | ﹤0.01% |
+1,729
| New | +$353K |
|
|
BCPC
2066
Balchem Corp
BCPC
$5.33B
| $350K | ﹤0.01% |
2,790
-30,560
| -92% | -$3.71M |
|
|
SIC
2067
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
| $350K | ﹤0.01% |
48,617
-9,425
| -16% | -$77.9K |
|
2068
Relay Therapeutics
RLAY
$3.99B
| $349K | ﹤0.01% |
+10,102
| New | +$438K |
|
2069
Sixth Street Specialty
TSLX
$1.68B
| $348K | ﹤0.01% |
16,543
-44,516
| -73% | -$956K |
|
2070
Pegasystems
PEGA
$4.85B
| $346K | ﹤0.01% |
+6,050
| New | +$396K |
|
2071
Gran Tierra Energy
GTE
$226M
| $345K | ﹤0.01% |
+49,245
| New | +$352K |
|
|
YELL
2072
DELISTED
Yellow Corporation Common Stock
YELL
| $345K | ﹤0.01% |
+39,199
| New | +$253K |
|
2073
MGP Ingredients
MGPI
$400M
| $344K | ﹤0.01% |
+5,823
| New | +$353K |
|
|
SHI
2074
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $343K | ﹤0.01% |
14,503
+3,936
| +37% | +$93.1K |
|
|
TRIB
2075
Trinity Biotech
TRIB
$8.4M
| $341K | ﹤0.01% |
+605
| New | +$436K |
|
Similar funds
Marshall Wace's Q1 2021 Portfolio in Review
As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.
- Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
- Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
- Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
- Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
- Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
- Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.
Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.